Kanakinumab (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kanakinumab" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

7nih.gov

4^th place

3^rd place

5doi.org

2^nd place

1wikipedia.org

low place

1landesbioscience.com

low place

1cines.fr

low place

1web.archive.org

1^st place

cines.fr

imgt.cines.fr

IMGT Link:http://imgt.cines.fr/3Dstructure-DB/cgi/details.cgi?pdbcode=8836 Arhivirano 2008-12-07 na Wayback Machine-u

doi.org

dx.doi.org

Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Dhimolea, Eugen (2010). „Canakinumab”. MAbs 2 (1): 3–13. DOI:10.4161/mabs.2.1.10328. PMC 2828573. PMID 20065636.
Lachmann, HJ; Kone-Paut I, Kuemmerle-Deschner JB et al. (2009-06-04). „Use of canakinumab in the cryopyrin-associated periodic syndrome”. New Engl J Med 360 (23): 2416–25. DOI:10.1056/NEJMoa0810787. PMID 19494217.
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.
David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.

landesbioscience.com

Dhimolea, Eugen (2010). „Canakinumab”. MAbs 2 (1): 3–13. DOI:10.4161/mabs.2.1.10328. PMC 2828573. PMID 20065636.

nih.gov

ncbi.nlm.nih.gov

Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Dhimolea, Eugen (2010). „Canakinumab”. MAbs 2 (1): 3–13. DOI:10.4161/mabs.2.1.10328. PMC 2828573. PMID 20065636.
Lachmann, HJ; Kone-Paut I, Kuemmerle-Deschner JB et al. (2009-06-04). „Use of canakinumab in the cryopyrin-associated periodic syndrome”. New Engl J Med 360 (23): 2416–25. DOI:10.1056/NEJMoa0810787. PMID 19494217.
Church LD, McDermott MF: Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther. 2009 Feb;11(1):81-9. PMID 19169963
Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN: Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009 Jun 4;360(23):2416-25. PMID 19494217
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.
David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.

web.archive.org

IMGT Link:http://imgt.cines.fr/3Dstructure-DB/cgi/details.cgi?pdbcode=8836 Arhivirano 2008-12-07 na Wayback Machine-u

wikipedia.org

sh.wikipedia.org

Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit